You are here

Effectiveness of GSK's malaria vaccine dwindles in 7 years

London

THE world's first malaria vaccine, developed by GlaxoSmithKline (GSK), provides some protection after three doses but its effect dwindles to almost nothing after seven years, scientists said on Wednesday.

Publishing a long-term study of the vaccine - called RTS,S or

sentifi.com

Market voices on:

Powered by GET.comGetCom